Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001213900-23-089579

Director bought 10,000 shares at $0.64 ($6,383)

From the SEC's structured data for this filing

Trades in this filing

WIGGANS THOMAS G · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-11-21 Purchase : show line 1 in the form +10,000 $0.64 $6,383 40,000 D
Open-market purchases · 10,000 sh · avg $0.64 · $6,383
Loading xslF345X05/ownership.xml…